Skip to main content

Flagship Ventures 2007 General Partner LLC

13F filer · CIK 0001508053
Last filed Aug 15, 2016
Inactive · not filing 13F
13F portfolio value$107MU.S. long equity reported on 13F
Positions4Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2016Reported Aug 15, 20164 positions
AGIOAgios Pharmaceuticals, Inc.$80.9M75.24%5.08%Not reportedQ4 2013
RNACCartesian Therapeutics, Inc.$23.1M21.50%9.23%NewQ2 2016
EBIOCarisma Therapeutics Inc.$3.2M2.98%Not reportedNot reportedQ1 2014
REGIRenewable Energy Group, Inc.$296K0.28%Not reportedNot reportedQ2 2014
Q4 2015Reported Feb 12, 20164 positions
AGIOAgios Pharmaceuticals, Inc.$125M82.23%5.12%Not reportedQ4 2013
MCRBSeres Therapeutics, Inc.$21M13.80%1.53%Not reportedQ2 2015
EBIOCarisma Therapeutics Inc.$5.74M3.77%Not reportedNot reportedQ1 2014
REGIRenewable Energy Group, Inc.$312K0.20%Not reported+3.8%Q2 2014
Q3 2015Reported Nov 13, 20155 positions
AGIOAgios Pharmaceuticals, Inc.$136M85.66%5.13%Not reportedQ4 2013
MCRBSeres Therapeutics, Inc.$17.8M11.17%1.53%Not reportedQ2 2015
EBIOCarisma Therapeutics Inc.$4.6M2.89%Not reportedNot reportedQ1 2014
REGIRenewable Energy Group, Inc.$268K0.17%Not reported-7.5%Q2 2014
BGMDBG Medicine, Inc.$181K0.11%3.96%0.0%Q4 2013
Q2 2015Reported Jul 28, 20155 positions
AGIOAgios Pharmaceuticals, Inc.$215M87.15%5.16%Not reportedQ4 2013
MCRBSeres Therapeutics, Inc.$24.9M10.10%1.97%NewQ2 2015
EBIOCarisma Therapeutics Inc.$5.38M2.18%Not reportedNot reportedQ1 2014
BGMDBG Medicine, Inc.$970K0.39%20.36%Not reportedQ4 2013
REGIRenewable Energy Group, Inc.$404K0.16%Not reported-62.9%Q2 2014
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.